JP2010510994A5 - - Google Patents

Download PDF

Info

Publication number
JP2010510994A5
JP2010510994A5 JP2009538564A JP2009538564A JP2010510994A5 JP 2010510994 A5 JP2010510994 A5 JP 2010510994A5 JP 2009538564 A JP2009538564 A JP 2009538564A JP 2009538564 A JP2009538564 A JP 2009538564A JP 2010510994 A5 JP2010510994 A5 JP 2010510994A5
Authority
JP
Japan
Prior art keywords
peptide
seq
immunogenic composition
composition
based immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009538564A
Other languages
English (en)
Japanese (ja)
Other versions
JP5177451B2 (ja
JP2010510994A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2007/002164 external-priority patent/WO2008064488A1/en
Publication of JP2010510994A publication Critical patent/JP2010510994A/ja
Publication of JP2010510994A5 publication Critical patent/JP2010510994A5/ja
Application granted granted Critical
Publication of JP5177451B2 publication Critical patent/JP5177451B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009538564A 2006-11-30 2007-11-30 インフルエンザワクチン製剤 Expired - Fee Related JP5177451B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86800806P 2006-11-30 2006-11-30
US60/868,008 2006-11-30
PCT/CA2007/002164 WO2008064488A1 (en) 2006-11-30 2007-11-30 Influenza vaccine formulation

Publications (3)

Publication Number Publication Date
JP2010510994A JP2010510994A (ja) 2010-04-08
JP2010510994A5 true JP2010510994A5 (cg-RX-API-DMAC7.html) 2011-01-27
JP5177451B2 JP5177451B2 (ja) 2013-04-03

Family

ID=39467397

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009538564A Expired - Fee Related JP5177451B2 (ja) 2006-11-30 2007-11-30 インフルエンザワクチン製剤

Country Status (6)

Country Link
US (2) US7807173B2 (cg-RX-API-DMAC7.html)
EP (1) EP2097103B1 (cg-RX-API-DMAC7.html)
JP (1) JP5177451B2 (cg-RX-API-DMAC7.html)
CN (1) CN101622009B (cg-RX-API-DMAC7.html)
CA (1) CA2670965C (cg-RX-API-DMAC7.html)
WO (1) WO2008064488A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008064488A1 (en) * 2006-11-30 2008-06-05 Variation Biotechnologies Inc. Influenza vaccine formulation
KR101701198B1 (ko) 2008-06-19 2017-02-01 배리에이션 바이오테크놀로지스 아이엔씨. 인플루엔자를 치료하기 위한 조성물 및 방법
WO2011138032A2 (en) * 2010-05-05 2011-11-10 Artemev, Timur Universal influenza vaccines and methods for their generation
CA2890084C (en) 2011-11-18 2021-05-04 Maura Ellen Campbell Synthetic derivatives of mpl and uses thereof
CA2995838A1 (en) 2015-08-19 2017-02-23 Rutgers, The State University Of New Jersey Novel methods of generating antibodies
US11261464B2 (en) 2016-09-20 2022-03-01 Boehringer Ingelheim Vetmedica Gmbh Promoters

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7118874B2 (en) * 1998-10-09 2006-10-10 Variation Biotechnologies Inc. Immunogenic formulation and process for preparation thereof
US6896881B1 (en) * 1999-09-24 2005-05-24 Mayo Foundation For Medical Education And Research Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
CN1163271C (zh) * 2000-08-10 2004-08-25 清华大学 一种合成肽流感疫苗的制备方法
JP4391827B2 (ja) * 2002-02-08 2009-12-24 バリエーション バイオテクノロジーズ インコーポレイティド 可変性ペプチドエピトープの免疫原性製剤及びその製造方法
JP2006519775A (ja) * 2003-03-07 2006-08-31 メルク エンド カムパニー インコーポレーテッド インフルエンザウイルスワクチン
CN101227919B (zh) * 2005-06-01 2011-10-05 变异生物技术公司 基于肽的流感疫苗制剂
US20090169576A1 (en) * 2005-10-26 2009-07-02 Roberto Crea Influenza combinatorial antigen vaccine
US9533036B2 (en) * 2005-11-07 2017-01-03 Microvax, Llc Methods for generating immune responses to influenza antigens with a secretable CD40L fusion protein
WO2008112017A2 (en) * 2006-10-10 2008-09-18 The Government Of The United States Of America, As Represented By The Secretary, Department Of Healtand Human Services Avian influenza vaccine
WO2008064488A1 (en) * 2006-11-30 2008-06-05 Variation Biotechnologies Inc. Influenza vaccine formulation

Similar Documents

Publication Publication Date Title
JP2010534684A5 (cg-RX-API-DMAC7.html)
JP2006006329A5 (cg-RX-API-DMAC7.html)
JP2009524695A5 (cg-RX-API-DMAC7.html)
JP2006213929A5 (cg-RX-API-DMAC7.html)
JP2010065037A5 (cg-RX-API-DMAC7.html)
IL247741B (en) Pharmaceutical preparations containing iron oxo-hydroxide, methods for their preparation and their uses
JP2010501534A5 (cg-RX-API-DMAC7.html)
JP2011526809A5 (cg-RX-API-DMAC7.html)
JP2013510581A5 (cg-RX-API-DMAC7.html)
JP2009533064A5 (cg-RX-API-DMAC7.html)
JP2010088434A5 (cg-RX-API-DMAC7.html)
JP2009504138A5 (cg-RX-API-DMAC7.html)
JP2010510994A5 (cg-RX-API-DMAC7.html)
JP2007510403A5 (cg-RX-API-DMAC7.html)
IL209304A0 (en) Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
JP2009520682A5 (cg-RX-API-DMAC7.html)
JP2006305390A5 (cg-RX-API-DMAC7.html)
JP2008533990A5 (cg-RX-API-DMAC7.html)
JP2008519810A5 (cg-RX-API-DMAC7.html)
JP2007508806A5 (cg-RX-API-DMAC7.html)
GB0704352D0 (en) "Peptide, compositions and uses thereof"
JP2009507965A5 (cg-RX-API-DMAC7.html)
JP2009507121A5 (cg-RX-API-DMAC7.html)
吴小霞 et al. 青海什多龙银铅锌矿床银的赋存状态研究
李田玉 某含金废料熔炼渣型试验研究